fbpx

U.S. Anti-Doping Agency (USADA)

USADA logo.

Global DRO logo in whiteSearch Medications & Ingredients

Click here to see how the sample collection process has been modified with COVID-19 safety protocols.

Urine Sample Collection Process

Drug testing will be a part of an athlete’s life as long as he/she chooses to compete at an elite level. It may not be the most glamorous part of an athlete’s career, but it is critical in the global fight for clean sport.

Athletes subject to USADA drug testing may be subject to both in- and out-of-competition testing. This page outlines the in-competition testing process for a urine sample collection. The procedures for providing and processing a sample collection during the out-of-competition testing process are similar and are depicted in the video to the left.

All videos are copyrighted property of the U.S. Anti-Doping Agency. The material contained within may not be reproduced, distributed, transmitted, or otherwise used, except with the express written permission of the U.S. Anti-Doping Agency.

Explore the Steps of the Urine Sample Collection Process

Click on each step to open the details.

Athlete Selection and Notification

swimmer and doping control officer graphicUSADA’s drug testing program allows for athletes to be selected for testing both at a competition (in-competition testing) or without any advanced notice (out-of-competition testing) which can occur at any time and at any location. Athletes will be notified of their selection for doping control, by a USADA Doping Control Officer (DCO) or USADA chaperone. At the time of notification, the athlete will be informed of their rights and responsibilities during the sample collection process and be asked to provide photo identification.

Doping Control Station

swimmer athlete and doping control officerFollowing notification, the athlete will remain under continuous watch (direct observation) of the DCO or chaperone. If the athlete has been notified for in-competition testing, they must immediately report to the doping control station. Under certain circumstances, an athlete may request a delay in reporting for valid reasons; however, this request may not be permitted if it is not possible for the athlete to be continuously chaperoned. Such circumstances may include:

  • Competing in further events;
  • Participation in a victory ceremony;
  • Fulfillment of media commitments;
  • Performing a warm down;
  • Obtaining necessary medical treatments;
  • Locating a representative and/or interpreter;
  • Obtaining photo identification; or
  • Completing a training session.

Provision of Sample

DCO directly observing the passing of the sampleDCO directly observing the passing of the sample. When ready to provide a sample, the athlete will be asked to select a sealed sample collection vessel from a choice of vessels. The athlete should check and inspect the collection vessel to ensure that it has not been tampered with and will be instructed to rinse their hands with only water before opening the vessel. The athlete representative may be present in the toilet area during the provision of the sample with the athlete’s permission and when agreed upon by the DCO.

The athlete will be asked to provide a urine sample of at least 90ml under direct observation of a DCO or witnessing chaperone of the same gender. For the DCO or chaperone to have a clear view of the sample being provided, the athlete will be asked to pull their shirt up to mid torso, pants down to mid-thigh and sleeves rolled up their elbows. As soon as the athlete is finished providing the sample, the DCO or chaperone will instruct the athlete to immediately secure the vessel with the lid.

Provision of the sample in the case of a minor will require a few additional protocols. Please follow the link to read the policy on minor athletes.

Sample Processing

After the sample is secured, the athlete and the DCO or chaperone will proceed back to the doping control station to begin the sample processing part of sample collection.

The athlete will first be asked to choose a sample collection kit containing the bottles in which the sample will be sent to the lab. Similar to the way the vessel was chosen, the athlete will choose from a choice of sample collection boxes and ensure that the container is not damaged or tampered with. The athlete will open the sample collection kit and inspect the contents of the package. Both the DCO and athlete will ensure that all sample code numbers on the bottles and sample collection kit box match.

The athlete will then divide the sample between the B Sample and A Sample bottles and seal them. The DCO will not handle any of the equipment during the procedure unless requested to do so by the athlete. The athlete is to maintain control of the sample until the sample is sealed.

Once the sample is sealed, the athlete will be asked to place the B Sample and A Sample bottles into plastic bags and into a cardboard box.

Sample Collection Forms

Athlete and DCO finishing paperworkThe DCO and athlete will complete sample collection forms together, either hard-copy or via the USADA Paperless Sample Collection System, to document the circumstances of the sample collection process. Additionally, In accordance with the instructions on the doping control official record (DCOR), the athlete should declare any substance or medication they may have taken. They also should provide details of any Therapeutic Use Exemptions (TUEs) they may have on file.

For information on medical declarations including TUEs, please click here.

The athlete should check the entire DCOR thoroughly to ensure that the information is accurate and correct. The athlete’s name is not on the form that goes to the laboratory.

The laboratory reports all results based on the unique sample code numbers. The athlete should keep a copy of the DCOR in a safe place.

The sample is then mailed by the DCO to the laboratory for analysis in a transport bag, ensuring a secure chain of custody. For information on laboratory sample analysis, please click here.

Finally, the athlete should include any comments on the athlete evaluation survey and return it to USADA.

To help ensure a level-playing field globally, elite athletes participate in no-notice, in-competition and out-of-competition urine and blood testing in accordance with the World Anti-Doping Agency’s (WADA) International Standards. The sample collection and analysis process is designed to ensure security of the sample during and after collection, as well as sample anonymity during the analysis process.

Click here to explore the six-step journey of a sample, from collection to storage.

Scroll to Top

SAMPLE COLLECTION VIDEO TRANSCRIPT

USADA is committed to making sport safe, fair, and authentic at all levels of competition, through independent and comprehensive anti-doping programs. One key component of a successful anti-doping program is strategic drug testing, in accordance with the World Anti-Doping Code. USADA’s gold standard testing program utilizes in-competition testing and out-of-competition testing, which can occur at any time and any location. Athletes selected for testing may be required to provide urine, blood, or both. This applies to U.S. Olympic and Paralympic athletes, International and Masters Level athletes, and Junior athletes.

When a doping control officer, or DCO, notifies athletes that they have been selected for testing, the DCO must show the athlete their credential. If the DCO is not the same gender as the athlete, they’ll be accompanied by a chaperone of the athlete’s gender who can supervise the provision of the sample. The athlete is then required to produce identification and stay within direct view of the DCO or chaperone until the test is concluded. Athletes are required to report immediately to an out-of-competition location or to the in-competition doping control station, unless the DCO approves a valid reason for reason for delay, such as cooling down, attending a medal ceremony, fulfilling a media commitment, or receiving medical attention. Athletes do have the right to have a representative present.

For urine samples, minor athletes are also required to have a third-party present in the toilet area where they can monitor the DCO or chaperone during the provision of the sample. Athletes with disabilities have the right to request necessary modifications to the testing process. All athletes are asked to provide a sample of at least 90 milliliters of urine under the direct observation of a DCO or witnessing chaperone. If 90 milliliters are not immediately available, athletes will store the partial sample in a secure vault and use another collection cup to secure the remaining sample when ready. After staying in view of the chaperone and then providing a full sample, athletes will be offered a choice of sealed sample collection equipment that contain two security bottles marked “A” and “B”. They should inspect the equipment prior to use, and the DCO should instruct the athlete to ensure that the alphanumeric code on the bottles match and correspond to the barcode on the outside of the box. This is critical, since the athletes name will not appear on the documentation sent to the lab, to ensure anonymity. Athletes will then divide their sample between the “A” and “B” sample bottles, secure the bottles, and seal them for shipping. Athletes are to maintain direct observation and control of their sample until it’s sealed.

A sample collection session may include a blood collection. Some USADA DCOs will be licensed or certified phlebotomists. But if they are not, a certified and/or licensed phlebotomist, called a Blood Collection Officer, or BCO, will perform the blood draw. Athletes are asked to stay seated for a period of time before blood is drawn. Less than two tablespoons of blood is needed for testing, which should not affect athletic performance.

After securing the sample, the DCO will review the Doping Control Official Record, or DCOR, with an athlete, at which time, they will declare their use of any medications, supplements, or treatments before signing the DCOR. Athletes are encouraged to discuss any concerns with the DCO and to provide feedback to USADA. Please visit USADA.org for more information about the sample collection process.